Significant changes in serum AST across hepatic histological biopsy grades: Prospective analysis of 3 cohorts receiving methotrexate therapy for rheumatoid arthritis

Journal of Rheumatology

Volumn 23, Issue 3, 1996, Pages 459-461

  Kremer, Joel M ^a   Furst, Daniel E ^c   Weinblatt, Michael E ^b   Blotner, Steven D ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c 1201 Ninth Ave Seattle W   (United States)

Author keywords

Liver; Liver function; Methotrexate

Indexed keywords

AMINOTRANSFERASE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; LIVER BIOPSY; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ASPARTATE AMINOTRANSFERASES; BIOPSY; COHORT STUDIES; FEMALE; HUMANS; LIVER DISEASES; MALE; METHOTREXATE; MIDDLE AGED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0029916174     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Kremer JM, Lee JK: The safety and efficacy of the use of methotrexate in long-term therapy for theumatoid arthritis. Arthritis Rheum 1986;29:822-31.
2. Weinblatt ME, Trentham DE, Fraser PA, et al.: Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis. Arthritis Rheum 1988;31:167-15.
3. Kremer JM, Lee JK: A long-term prospective study of the use of methotrexate in rheumatoid arthritis: update after a mean of fifty-three months. Arthritis Rheum 1988;31:577-89.
4. Furst DE, Erikson N, Clute I, Koehnke R, Burmeister LF, Kohler JA: Adverse experience with methotrexate during 176 weeks of a longterm prospective trial in patients with rheumatoid arthritis. J Rheumatol 1990:17:1628-35.
5. Wolfe F, Hawley DJ, Cathey MA: Termination of slow acting antirheumatic therapy in rheumatoid arthritis: A 14-year prospective evaluation of 1,017 consecutive starts. J Rheumatol 1990; 17:994-1002.
6. Kremer JM, Phelps CT: Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis: Update after a mean of 90 months. Arthritis Rheum 1992,35:138-45.
7. Weinblatt ME, Weissman BN, Holdsworth DE, et al.: Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis: 84 month update. Arthritis Rheum 1992;35:129-37.
8. Morgan SL, Baggott JE, Vaughn WH, et al.: The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 1990,33:9-18.
9. Furst DE, Kremer JM: Methotrexate in rheumatoid arthritis. Arthritis Rheum 1988;31:305-14.
10. Kremer JM, Alarcon GA, Lightfoot RW, et al. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. Arthritis Rheum 1994;37:316-28.
11. Kremer JM, Lee RG, Tolman KG: Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy: A prospective study with baseline and sequential biopsy samples. Arthritis Rheum 1989;32:121-7.
12. Kremer JM: Long-term prospective sequential liver biopsies in patients with rheumatoid arthritis on weekly oral methotrexate (abstr). Arthritis Rheum 1990;(suppl 9) 33:540.
13. Kremer JM, Kaye GI, Kaye NW, Ishak KG, Axiotis CA: Light and electron microscopic analysis of sequential liver biopsy samples from patients with rheumatoid arthritis receiving long-term methotrexate therapy. Follow-up over prolonged treatment intervals and corrrelation with clinical and laboratory variables Arthritis Rheum 1995,38.1194-203.
14. Arnett FC, Edworthy SM, Bloch DA, et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1987;31:315-24.
15. Rocnigk HH, Auerbach R, Maibach HI, Weinstein GO: Methotrexate guidelines - revised. J Am Acad Dermatol 1982;6:145-55.
16. Kremer JM, Koff R: A debate: Patient with rheumatoid arthritis on methotrexate should have liver biopsies. Semin Arthritis Rheum 1992;21:376-86.